Granules India Ltd., incorporated in the year 1991, is a Mid Cap company (having a market cap of Rs 12,595.12 Crore) operating in Pharmaceuticals sector. Granules India Ltd. key Products/Revenue ...

Aditya Birla SL Pure Value Fund (G) 141.67 25,46,492 2.39 Aditya Birla SL Pure Value Fund (IDCW) 141.67 25,46,492 2.39 Aditya Birla SL Pure Value Fund - Direct (G) 141.67 25,46,492 2.39 Aditya Birla ...

Granules India receives USFDA approval for its generic Lisdexamfetamine Dimesylate capsules, indicated for the treatment of ADHD and Binge Eating Disorder in adults and children. Jan 30, 2025 14:05 ...

Get daily newsletters around different themes from livemint.

The drug firm plans to invest about Rs 180 crore on a Multiple Units Pellet System (MUPS) block, around Rs 250 crore on expanding active pharmaceutical ingredients (API) capacity.

The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.

Granules India Limited is a large-scale vertically integrated company founded in March 18th, 1991 manufacturing Active Pharmaceutical Ingredient (API), Pharmaceutical Formulation Intermediate (PFI ...

Licious, backed by Temasek Holdings Pte, aims to become profitable by 2026 as it gears up for a potential IPO valuing over $2 billion. The firm is expanding into brick-and-mortar stores, enhancing ...

Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.

US President Donald Trump questioned the $21 million US allocation for voter turnout in India, during the FII PRIORITY Summit. He highlighted India's strong economy and high tariffs on US goods.

India News Live: Stay informed with our live blog covering India’s latest in politics, economy, crime, and general news. Get real-time updates on political developments, financial trends, crime ...